Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
51.54
-3.78 (-6.83%)
At close: Jul 2, 2024, 4:00 PM
51.77
+0.23 (0.45%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Viking Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
5.68B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.35B
Acadia Healthcare Company 2.99B
R1 RCM 2.31B
Lantheus Holdings 1.37B
Tempus AI 562.02M
Glaukos 326.43M
Revolution Medicines 4.57M
Cytokinetics 3.75M
Revenue Rankings